Garfield Sara, Francis Sally-Anne, Smith Felicity J
Department of Practice and Policy, The School of Pharmacy, University of London, 29-39 Brunswick Square, London WC1N 1AX, UK.
Patient Educ Couns. 2004 Nov;55(2):241-6. doi: 10.1016/j.pec.2003.09.011.
Fifty one patients beginning courses of antidepressant medication were recruited from general practice surgeries in two health authorities in London and interviewed on two occasions. Respondents were asked about their experiences of using antidepressant medication, including their information needs and the level of involvement which they had had in making decisions about their medication. Analysis was carried out using qualitative procedures. The study identified information needs which were unmet at the start of treatment, including the impact of adverse drug reactions on patients' lives, the very gradual process of recovery and information regarding dosage prescribed in the context of minimum and maximum dosages. Respondents also had a broad view of the term dependency that needed to be addressed. However, some respondents reported that they experienced difficulty in absorbing information given during the initial consultation. Therefore developing strategies for reinforcement of information would be advantageous. Patients involvement in decision making varied between respondents and at different points in therapy.
从伦敦两个卫生当局的全科医疗诊所招募了51名开始服用抗抑郁药物疗程的患者，并对他们进行了两次访谈。受访者被问及他们使用抗抑郁药物的经历，包括他们的信息需求以及他们在药物治疗决策中的参与程度。采用定性方法进行分析。该研究确定了治疗开始时未得到满足的信息需求，包括药物不良反应对患者生活的影响、非常缓慢的康复过程以及关于规定剂量在最小和最大剂量范围内的信息。受访者对需要解决的“依赖性”一词也有广泛的看法。然而，一些受访者报告说，他们在吸收初次咨询时提供的信息方面遇到困难。因此，制定强化信息的策略将是有益的。患者在决策中的参与程度因受访者不同以及治疗的不同阶段而有所差异。
